Programme/Presentations 2018

Due to limitations regarding data volume, we cannot display video files embedded in the presentations.

Thursday, 6 December

CAROTID ARTERY DISEASE (CAD) SESSION

* Competing for the MAC Award

	09.00-10.35	CAD 1 \| Lecture Hall B Clinical and imaging variables in asymptomatic carotid patients with an increased late stroke risk – a critical review of the ESVS/ESC guidelines 2017
		Chair: Gert de Borst, Holger Poppert
	Barbara Rantner	Clinical variables with an increased late stroke risk
	David Spence	Spontaneous embolisation on TCD and carotid plaque features
	Peter Ringleb	Silent infarction and impaired cerebrovascular reactivity
	Kosmas Paraskevas	Grade of carotid stenosis and stenosis progression
	Jonathan Nadjiri	MRI features of unstable carotid plaques
	Jens Göttler	Multi-modal MRI identifies carotid stenosis patients with reduced cerebral blood flow and oxidative metabolism
	Alison Halliday	Keynote Lecture: CEA or CAS for asymptomatic carotid stenosis – which patients benefit most?

	11.00-12.25	CAD 2 \| Lecture Hall B More news on carotid revascularization strategies and long-term outcomes in (a)symptomatic patients
		Chair: Peter Ringleb, Kornelia Kreiser, Michael Kallmayer
	Christos Liapis	Total occlusion of the internal carotid artery – not a benign condition
	Kosmas Paraskevas	Outcomes following eversion vs. conventional CEA in RCTs and observational studies – a systematic review
	Armelle Meershoek*	Long term outcomes of hybrid revascularization for extracranial symptomatic carotid artery tandem stenosis
	Klaus Mathias	Early and one year data from the Scaffold (micromesh) CAS Trial
	Sumaira MacDonald	Control of the microembolic burden of the carotid bifurcation lesion: comparison of various endovascular strategies
	Ralf Kolvenbach	Transcarotid stenting with flow reversal: does the kind of stent matter?
	Marc Schermerhorn	Keynote lecture: Transcarotid stenting (T-CAR) vs. CEA and transfemoral CAS in the SVS Vascular Quality Initiative

	12.30-12.50	Special Lecture 1 \| Lecture Hall B
	Hans Förstl	Cognitive impairment and dementia in politicians

	13.30-14.55	CAD 3 \| Lecture Hall B Carotid Stenosis Trialist Collaboration (CSTC) session
		Chair: Alison Halliday, Claus Zimmer, Leo Bonati
	Tilman Reiff	Stroke and TIA rates at one year in SPACE-2: BMT vs. CEA versus CAS in asymptomatic carotid stenosis
	Richard Bulbulia	Current status and perspectives of ACST-2, CREST-2, and ECST-2
	Gert de Borst	Safety of CEA and CAS in patients with a history of coronary heart disease in EVA-3S, SPACE, ICSS, and CREST
	Christoph Knappich	Local anesthesia reduced the 30-day risk of stroke or death after symptomatic CEA – metaanalysis of five RCTs
	Dylan Morris*	Risk factors for major operative complications following asymptomatic CEA – 4.440 CEA from VACS, ACAS, ACST-1, and GALA
	Evelien de Vries*	Carotid stent failure as a predictor for periprocedural stroke or death after CAS – a substudy from ICSS
	Leo Bonati	Keynote Lecture: Immediate, intermediate, and long-term results after CEA and CAS in four RCTs on symptomatic carotid stenosis

	15.00-15.25	Special Lecture 2 \| Lecture Hall B
	Christian Baars	Deadly superbugs from Pharma factories – an investigative report from the NDR Hamburg

	17.25-18.30	CAD 4 \| Lecture Hall C Short communications on Carotid Artery Diseases
		Chair: Kosmas Paraskevas, Tilman Reiff
	Klaus Mathias	Carotid artery aneurysms – what endovascular treatment can achieve
	Vanessa Pourier	Gadolinium enhancement and white matter lesions in extracranial carotid artery aneurysms
	Astrid Hoving	The performance of ultrasound particle image velocimetry in a carotid artery phantom with stent
	Christoph Schäffer	Non-invasive assessment of carotid plaque burden with tomographic ultrasound
	Armelle Meershoek	Treatment of internal carotid artery NEar occlusiON (NEON study): an individual patient data meta-analysis
	Ihor Kobza	The choice of the optimal method of surgical correction of atherosclerotic carotid lesions
	Peter Konstantiniuk	The ASA classification predicts the ipsilateral stroke free survival in asymptomatic octogenarians with elective CEA
	Evelien de Vries	Standardization of semiautomatic tortuosity measurements in the carotid artery
	Leonie Fassaert	Defining the awake blood pressure in patients undergoing CEA
	Pedro Pinto Sousa	Moderate (50%-69%) symptomatic carotis stenosis – what should we do?
	Michael Kallmayer	Eligibility to RCTs, do RCTs represent the real world?

AORTIC (AOR) SESSION

* Competing for the MAC Award

09.00-10.40	AOR 1 \| Lecture Hall C Short communications on Aortic Diseases
	Chair: Rebecka Hultgren, Benedikt Reutersberg, Jaroslav Pelisek
Ahmed Eleshra	Different zones (0-2) of hybrid de-branching endovascular aortic repair: outcomes and stroke analysis
Mikhail Chernyavskiy	Mid-term results of hybrid aortic arch repair
Pedro Pinto Sousa	Acute aortic syndrome – three typical case presentations
Arnaud Kerzmann	Results of left subclavian artery revascularization prior to elective TEVAR
Ahmad Naga	Combined TEVAR and EVAR to treat thoracic Type I B endoleak and infrarenal AAA
Rita Augusto	Late Type I A endoleak after EVAS: a unique challenge
Albert Busch	Angiogenesis-inhibition and AAA
Shengliang Liu	Role of neutrophil extracellular traps in AAA disease development and progression
Jasamine Coles-Black	An easily reproducable 3D printed AAA model using open source digital tools
Pedro Pinto Sousa	Endovascular aneurysm repair in octogenarians
Jacinta Campos	Mycotic aortic aneurysm secondary to intravesical BCG instillation – is an endovascular approach effective?
Makhmud Akhmad	Endovascular diagnostics and treatment of acute abdominal bleedings after upper GI surgery
Matthias Trenner	Intraarterial CEUS – first experience with a new technique to detect early endoleaks in EVAR
Stefan Ockert	Short report: endovascular one stop shopping: EVAR + TAVI
Lars Lönn	Computer-controlled aortic occlusion (REBOA) for the treatment of cardiac arrest and bleedings
Konstantinos Spanos	Pre- and postoperative factors associated with the persistence of Endoleak Type II after EVAR in the first year of follow up
Dittmar Böckler	The impact of low profile devices for TEVAR procedures
Piotr Kasprzak	Endograft explantation and aortic reconstruction in a patient with AAA rupture following EVAS (video presentation)

11.00-12.30	AOR 2 \| Lecture Hall C Dismantling AAAs – novel insights into disease mechanisms and future therapies
	Chair: Lars Maegdefessel, Rebecka Hultgren
Rebecka Hultgren	Gender aspects in AAA disease
Marc Bailey	Vascular smooth muscle cell remodelling potentiates abdominal aortic aneurysm growth
Rachael Forsythe	Multi-modality molecular and cellular imaging to predict AAA growth: towards personalised assessment of disease
Thorsten Kessler	Implementing genetics into clinical practice in cardiovascular disease management
Wolf Eilenberg*	The association of neutrophil activation markers with morphological features of AAA
Markus Wagenhäuser*	Nicotine is a regulator of segmental aortic stiffening – implications for AAA development
Valentina Paloschi*	Aorta-on-a-chip: a novel tool to gain molecular insights into aneurym disease

13.30-15.00	AOR 3 \| Lecture Hall C Biomechanical simulation of aortic aneurysms
	Chair: Wolfgang Wall, Michael Gee, Markus Kleemann
Thomas Gasser	Predicting three-dimensional AAA growth from CT-A images
Stephane Avril	Patient-specific numerical simulation of endovascular aneurysm repair
Michael Gee	In Silico EVAR for Abdominal Aortic Aneurysms
Tina Cohnert	Advances in biomechanical and structural AAA wall analysis
Joy Roy	Biomechanical modeling of AAA growth and rupture – a clinical perspective
Benedikt Reutersberg	The SCAN study reveals that cardiovascular patients should be ultrasound-screened for AAA

PERIPHERAL ARTERIAL DISEASE (PAD) SESSION

* Competing for the MAC Award

15.40-17.05	PAD 1 \| Lecture Hall B Innovative imaging and below-the-knee treatment modalities
	Chair: Jonathan Nadjiri, Anders Wanhainen
Jean-Paul de Vries	DETECT-PAD II: computerized and patient specific model to determine pressure gradients in borderline stenosis with MRA/CTA
Jos van den Berg	Zero contrast procedure by use of unenhanced MRA and CO2 angiography
Michael Rasper	3D non-contrast-enhanced ECG-gated MR angiography of the lower extremities
Jean-Paul de Vries	The REPEAT study: validation of perfusion angiography measurements for below-the-knee arteries in critcal limb ischaemia
Marianne Brodmann	Early results from a RCT on below-the-knee drug-eluting balloons
Achim Neufang	Surgical arterialisation of the plantar venous system for foot salvage after failed endovascular or operative revascularisation

17.25-18.30	PAD 2 \| Lecture Hall B Peripheral and mesenteric vascular emergencies
	Chair: Achim Neufang, Alexander Zimmermann
Anders Wanhainen	Open or endovascular revascularization in the treatment of acute lower limb ischaemia
Kerstin Stoklasa	Outcomes of a consecutive series of 708 patients with acute limb ischaemia – a single center report from Munich
Heli Järve*	Acute mesenteric ischaemia: irreversible vs. reversible bowel damage – a single center experience
Shelby Cooper*	Mesenteric vascular injuries in trauma: a National Trauma Data Bank (NTDB) study from the US
Adel Hussein Kamhawy	Arterial injury associated with pediatric supracondylar humerus fracture – exploration or observation?
Ralf Kolvenbach	Keynote Lecture: Civilian and pediatric vascular trauma management – an overview

MINI - SYMPOSIUM 1

13.30-14.15	Mini-Symposium 1 \| Conference Room 1 Advance Therapy Outcomes in fenestrated and branched EVAR (Industry Sponsored)
Stefan Ockert	The workflow during complex EVAR – mobile vs. fixed C-Arms (with a focus on ARTIS Pheno)
Eric Verhoeven	The workflow during FEVAR in the hybrid OR with fusion imaging (syngo EVAR Guidance)
Dittmar Böckler	Intraoperative 3D assessment of FEVAR and BEVAR – EVAR guidance and distorsion correction

SPECIAL SESSION 1

15.30-17.00	SPECIAL SESSION 1 \| Lecture Hall C Hot topics in radiation protection 2018
	Chair: Alexander Oberhuber, Thomas Schmitz-Rixen, Christos Liapis
Tina Cohnert	Advanced radiation protection in the hybrid OR with Zero Gravity
Dittmar Böckler	Practical tips in radiation protection for surgical staff in the hybrid OR
Heiko Wendorff	Mid-term effects of an Intensive radiation-protectionTraining on the IntraoperativeX-ray-radiation exposure in the hybrid OR
Stefan Ockert	Radiation exposure during C-arm supported EVAR with the Siemens Pheno system
Bijan Modarai	Risks associated with protracted low dose radiation exposure
Dittmar Böckler	Evidence of radiation induced cataracts and brain tumors
Stefan Ockert	EVAS might be associated with a decrease in intraoperative radiation dose as compared to EVAR

Friday, 7 December

CAROTID ARTERY DISEASE (CAD) SESSION

* Competing for the MAC Award

08.30-10.05	CAD 5 \| Lecture Hall C Carotid Artery Disease (CAD) – from genes to therapies
	Chair: Jan Nilsson, Lars Maegdefessel
Martin Dichgans	Stroke Genetics: discovery, biology, and clinical implications
Andrew Baker	Targeting SMCs through ncRNA modulation
Jan Nilsson	Factors associated with progression of carotid disease in high risk patients
Judith Sluimer	Interplay of oxygen sensors, inflammation, and cholesterol metabolism in atherosclerosis
Pirkka Vikatmaa	Morphology and histology of silent and symptom-causing atherosclerotic carotid plaques – the Helsinki CEA Study 2
Hanna Winter*	Long non-coding RNA NUDT6 regulates fibrous cap thickness in advanced atherosclerosis
Joachim Schmidt*	Expression of human somatostatin receptors and glucose transporters in carotid artery stenosis and aneurysms

10.30-11.40	CAD 6 \| Lecture Hall C Carotid plaque burden and vulnerability – assessment and clinical impact
	Chair: Eva Bartels, Richard Bulbulia
David Spence	Keynote Lecture: Carotid plaque burden predicts future cardiovascular events – why and how I do it!
Steven Rogers	Will carotid plaque volume assessed by 3D tomographic ultrasound be an alternative indicator for CEA or CAS?
Holger Poppert	How to detect and to stratify DUS findings at the carotid bifurcation (echolucency, ulceration, etc.)
Marjolijn Rots*	Correlation between plaque characteristics and presence of preoperative white matter lesions in patients undergoing CEA
Igor Koncar	TAXINOMISIS – a multidisciplinary EU project on stratification of patients with carotid artery disease

AORTIC (AOR) SESSION

* Competing for the MAC Award

08.30-10.05	AOR 4 \| Lecture Hall B The new AAA guidelines from the SVS, ESVS, Germany, and UK (NICE)
	Chair: Julian Scott, Matthias Trenner, Eric Verhoeven
Anders Wanhainen	Keynote Lecture: The new ESVS guidelines – what is new and what is different from the 2017 SVS AAA guidelines?
Sebastian Debus	Are there any different recommendations in the 2018 AAA guidelines from the German Vascular Society (DGG)?
Mike Wyatt	Changes to the management of patients with AAA in the UK: is NICE out of touch with worldwide best practice?
Athanasios Giannoukas	Some small AAAs (4.5-5.5 cm) should be treated - how to select them?
Thomas Schmitz-Rixen	How valid is the 5/5.5cm diameter threshold for AAA repair and do we need new RCTs to improve the evidence?
Igor Koncar	Morphological predictors of an increased AAA rupture risk
Clark Zeebregts	Accuracy of routine endoscopy diagnosing colonic ischaemia after AAA repair – a meta-analysis

10.30-12.00	AOR 5 \| Lecture Hall B Endoleak prevention and management in complex aortic aneurysms
	Chair: Ralf Kolvenbach, Mike Wyatt
Lars Lönn	Qualitative systematic review of studies reporting on re-interventions after elective EVAR
Marc Schermerhorn	Selected Type I and III EL at completion of FEVAR are safe to observe
Colin Bicknell	Endovascular strategies for treatment of Type I EL in EVAR
Albert Busch	Expansion and atrophy – aortic wall development after EVAR with endoleak Type II
Jean-Paul de Vries	Determinants of successful and unsuccessful deployment of EndoAnchors in hostile necks – evaluation of >300 implants
Athanasios Giannoukas	Expanding the borders in the treatment of pararenal AAAs with Ch-EVAS
Clark Zeebregts	The GLOBAL FACT Registry: a world-wide registry with core lab analysis of fenestrated Anaconda for complex aneurysms
Alexander Oberhuber	The (JOTEC®) iliAc BRAnch device for exclusion of Hypogastric Artery aneurysMs – ABRAHAM trial

12:30-12:45	SPECIAL LECTURE 3 \| Lecture Hall C
Julian Scott	Sarcopenia and outcomes in vascular surgery

13.00-14.20	AOR 6 \| Lecture Hall B Ascending aorta and aortic arch
	Chair: Dittmar Böckler, Piotr Kasprzak
Martin Czerny	The EACTS/ESVS expert consensus document on thoracic aortic pathologies affecting the aortic arch
Ralf Kolvenbach	Status of ascending aortic stent grafts in true aneurysms
Martin Czerny	Total endovascular treatment of aortic arch pathologies using branched endografts
Celia Riga	Contact force assessment in the arch during TEVAR: how do different graft designs perform?
Jonathan Nadjiri	Assessment of flow-displacement and wall-shear-stress by 4D aortic MRA
Ali Shahriari	Repair of acute DeBakey I dissections using a novel dissection – specific arch hybrid graft (AMDS)

14.50-16.40	AOR 7 \| Lecture Hall B Thoracic/Thoraco-abdominal aneurysm and dissections
	Chair: Tina Cohnert, Alexander Zimmermann
Dittmar Böckler	Prevalence of the CTA-based morphological DISSECT predictors in uncomplicated Stanford Type B aortic dissection
Igor Koncar	Early TEVAR in acute Type B dissection
Bijan Modarai	Contemporary treatment of Type B aortic dissection: is there a need for a disease specific approach to endografting?
Eric Verhoeven	Treatment of chronic aortic dissections with fenestrated and branched endografts
Celia Riga	Frozen elephant trunk techniques for chronic Type B dissections
Athanasios Katsargyris	Inner branches as an additional option besides fenestrations and branches in TAAA branched grafting
Colin Bicknell	Prevention and revision of TEVAR utilising EndoAnchors to reduce and treat endoleak
Sebastian Debus	The SPIDERgraft: can this novel technique decrease complications after thoracoabdominal repair?
Christos Liapis	Side effects of TEVAR and EVAR on the heart – myth or reality?
Christian Reeps	Role of abdominal and thoracic aortic surgery in radical cancer resection

PERIPHERAL ARTERIAL DISEASE (PAD) SESSION

* Competing for the MAC Award

12.45-14.30	PAD 3 \| Lecture Hall C Challenges in PAD – long and calcified lesions, in-stent-restenosis, CLI, and wound healing
	Chair: Marianne Brodmann, Heiko Wendorff, Adel Hussein Kamhawy
Thomas Zeller	Keynote Lecture: Technological advances in the endovascular treatment of calcified peripheral lesions?
Pirkka Vikatmaa	Multimodal revascularization strategies in CLI – the Helsinki approach
Jean-Paul de Vries	2 year results of the RAPID trial – RCT comparing Legflow DCB with Supera stenting vs. Supera alone for SFA lesions
Gunnar Tepe	2 year results of the COPA CABANA RCT of DCB vs. PTA for femoro-popliteal in-stent restenosis
Jos van den Berg	Current status of in-stent restenosis treatment in the SFA
Thomas Zeller	EffPac-Trial: Effectiveness of LUMINOR® DCB versus POBA in the SFA
Martin Lawaetz*	Is stenting of the superficial femoral artery as good as bypass surgery? Data from the Danish Vascular Registry
Alexander Zimmermann	The SVS objective performance goals are achievable for surgical therapy in a consecutive CLI all-comers cohort
Alexander Gombert*	Closed-incision negative-pressure therapy reduces vascular surgical site infections: the randomized AIMS trial
George Geroulakos	Time of complete healing of leg ulcers following revascularization for critical limb ischaemia

14.50-15.50	PAD 4 \| Lecture Hall C Update on lipid-lowering therapy in carotid and peripheral atherosclerosis
	Chair: Christine Espinola-Klein, Richard Bulbulia
David Spence	Best medical treatment for asymptomatic carotid disease – optimal LDL levels are achievable!
Richard Bulbulia	Intensive lipid-lowering for plaque stabilisation and regression? Implications for surgeons and our patients!
Barbara Rantner	Cardiovascular morbidity and mortality in patients with intermittent claudication – medical long-term intervention is a MUST
Mark Schermerhorn	Survival after lower extremity revascularization for critical limb-threatening ischaemia (CLTI) is better with high-dose statin
Thomas Stadlbauer	PCSK9 inhibitor evolocumab in patients with and without PAD – even better than statins?

15.50-16.40	PAD 5 \| Lecture Hall C Update on periprocedural and long-term platelet inhibition and anticoagulation in PAD
	Chair: Barbara Rantner, Klaus Mathias
Christine Espinola-Klein	Update on periprocedural and long-term antithrombotic management in PAD
Thomas Stadlbauer	Platelet inhibition PLUS low-dose anticoagulation – a new paradigm for all PAD patients?
Michael Spannagl	How to assess and individualize platelet inhibition in PAD
Marianne Brodmann	Cardiovascular outcomes after lower extremity endovascular or surgical revascularization – the EUCLID trial

17.00-18.00	PAD 6 \| Lecture Hall C Short communications on Peripheral Arterial Disease
	Chair: Christoph Knappich, Christian Reeps, Mohamed Ayman Nagib
Dmitry Dombrovsky	Transplantation of stem cells of different origin for the treatment of lower limb ischaemia
Akshitha Kesharaju	Sarcopenia as predictor of mortality and morbidity following major lower limb amputation
Mohamed Ayman Nagib	Transbrachial approach as an alternative method in the management of aortoiliac occlusive arterial diseases
Sabine Dallmann-Sieber	Acute occlusions of the infrarenal aorta – single-center experience of 68 patients in a 14-year period
Bianca Marinelli Teixeira	Rare atherosclerotic aneurysms of the dorsalis pedis artery in young women – case reports and literature review
Sohiel Nagib	Cost-effectiveness of CO2 as contrast medium for the endovascular treatment of PAOD in renal dysfunction
Yuriy Levchak	Adventitial cystic disease of the lower extremity main vessels

MINI - SYMPOSIUM 2+3

12.30-13.30	Mini-Symposium 2 \| Conference Room 1 The venous challenge – successful strategies to treat venous lesions (Industry Sponsored)
Tobias Steinke	The endovascular option for AV-fistula creation
Tobias Steinke	How to treat AV-fistula stenosis best
Houman Jalaie	The right way to treat chronic obstructive venous lesions – tips and tricks in diagnostic, indication, and treatment
Mohammad E. Barbati	What did we learn from the "Attract"-Study?

15.00-16.00	Mini-Symposium 3 \| Conference Room 1 Acute Type A Dissections: changing paradigms? (Industry Sponsored)
	Chair: Ali Shahriari, Martin Czerny

SPECIAL SESSION 2

17.00-18.05	SPECIAL SESSION 2 \| Lecture Hall B Team training, simulation, and augmented reality in the hybrid OR
	Chair: Colin Bicknell, Albert Busch
Mark Kaschwich*	A modular approach for an endovascular training environment using rapid prototyping as part of the Nav-EVAR project
Markus Kleemann	Augmented reality for navigated EVAR
Thomas Liebig	Metric-based virtual reality simulation – a paradigm shift in training for severe stroke
Celia Riga	An optimised team training for EVAR & TEVAR – how do you set it up and what is the evidence?
Matthias Trenner	The volume-outcome effect in AAA surgery indicates that trained teams perform better in elective and emergency settings
Heiko Wendorff	3D simulation in the Hybrid OR – just a gimmick or a valuable tool?

Saturday, 8 December

VENOUS (VEN) SESSION

09.00-10.00	VEN 1 \| Lecture Hall B Short communications on Venous Diseases
	Chair: Claus-Georg Schmedt, Rolf Weidenhagen
Luís Gamas	Venous stenting: initial experience and follow up in a Portuguese center
Mohamed Ayman Nagib	Laser crossectomy vs. anterior accessory saphenous vein laser ablation for anterior accessory saphenous vein reflux
Sohiel Nagib	Acute upper extremity deep vein thrombosis (DVT) – indications and effectiveness of superior caval filters
Mohamed Ismail	Role of inferior vena cava filter insertion prior to thrombolysis of acute iliofemoral deep venous thrombosis
Mangesh Tarte	Inferior caval obstruction – limited role of endovenous therapy
Andrij Nykonenko	Diagnostic management of the „nutcracker syndrome“
Mangesh Tarte	Combined role of laser ablation, ethanol embolisation, and foam sclerotherapy in the treatment of venous malformations
Adel Hussein Kamhawy	Surgical management of high- and low-flow vascular malformations

10.00-11.05	VEN 2 \| Lecture Hall B Acute and chronic deep vein thrombosis (DVT) – conservative and recanalizing strategies
	Chair: Jan Beyer-Westendorf, Karin Pfister
Armando Mansilha	Treating acute DVT with DOACs – advances and challenges
Viktor Pavlychenko	Surgical vs. conservative treatment of deep venous thrombosis: follow-up and quality of life
Stefan Ockert	Quality of life and post-thrombotic syndrome after surgical thrombectomy of acute iliofemoral DVT
George Geroulakos	Complications of endovascular treatment of May-Thurner syndrome
Houman Jalaie	Technical advances in recanalizing chronic venous obstructions – „skipped Y“ and femoral endophlebectomy

11.30-13.00	VEN 3 \| Lecture Hall B New developments in lower leg varicose vein disease
	Chair: Armando Mansilha, Houman Jalaie
Reshaabi Srinanthalogen	A novel view at the pathogenesis of varicose veins: proteomic analysis
Jan Beyer-Westendorf	SUPRISE – a RCT on thromboembolic complications in superficial-vein thrombosis under Rivaroxaban or Fondaparinux
Tobias Hirsch	Interventional treatment of perforator veins
Christian Reeps	Is high ligation still an option in superficial-vein thrombosis close to the sapheno-femoral junction?
Thomas Pröbstle	Current status of non-termal/non-tumescent saphenous ablation
Claus-Georg Schmedt	LEVEL-2 trial – Endovenous Laser Therapy (EVLT) with long wavelength (1940nm) and reduced energy density
Tobias Hirsch	What do we know about the allergenic risk of adhesive vein treatments?

13.30-14.45	VEN 4 \| Lecture Hall B The 2015 ESVS guidelines on chronic venous diseases – a critical review
	Chair: Thomas Pröbstle, Uta Werthern
Armando Mansilha	Keynote lecture: Why the current international guidelines are not always accurate to define the best technique for varicose veins
Mike Wyatt	Multimodal treatment of small saphenous vein reflux
Rolf Weidenhagen	Multimodal treatment of greater saphenous vein reflux
Karin Pfister	Periprocedural and long-term compression therapy – indications, evidence, and outcomes
Houman Jalaie	The postthrombotic syndrome – prevention and recanalizing treatment strategies

06–08 December | Klinikum rechts der Isar | Munich | Germany

Programme/Presentations 2018

Thursday, 6 December

09.00-10.35

CAD 1 | Lecture Hall B Clinical and imaging variables in asymptomatic carotid patients with an increased late stroke risk – a critical review of the ESVS/ESC guidelines 2017

11.00-12.25

CAD 2 | Lecture Hall B More news on carotid revascularization strategies and long-term outcomes in (a)symptomatic patients

12.30-12.50

Special Lecture 1 | Lecture Hall B

13.30-14.55

CAD 3 | Lecture Hall B Carotid Stenosis Trialist Collaboration (CSTC) session

15.00-15.25

Special Lecture 2 | Lecture Hall B

17.25-18.30

CAD 4 | Lecture Hall C Short communications on Carotid Artery Diseases

09.00-10.40

AOR 1 | Lecture Hall C Short communications on Aortic Diseases

11.00-12.30

AOR 2 | Lecture Hall C Dismantling AAAs – novel insights into disease mechanisms and future therapies

13.30-15.00

AOR 3 | Lecture Hall C Biomechanical simulation of aortic aneurysms

15.40-17.05

PAD 1 | Lecture Hall B Innovative imaging and below-the-knee treatment modalities

17.25-18.30

PAD 2 | Lecture Hall B Peripheral and mesenteric vascular emergencies

13.30-14.15

Mini-Symposium 1 | Conference Room 1 Advance Therapy Outcomes in fenestrated and branched EVAR (Industry Sponsored)

15.30-17.00

SPECIAL SESSION 1 | Lecture Hall C Hot topics in radiation protection 2018

Friday, 7 December

08.30-10.05

CAD 5 | Lecture Hall C Carotid Artery Disease (CAD) – from genes to therapies

10.30-11.40

CAD 6 | Lecture Hall C Carotid plaque burden and vulnerability – assessment and clinical impact

08.30-10.05

AOR 4 | Lecture Hall B The new AAA guidelines from the SVS, ESVS, Germany, and UK (NICE)

10.30-12.00

AOR 5 | Lecture Hall B Endoleak prevention and management in complex aortic aneurysms

12:30-12:45

SPECIAL LECTURE 3 | Lecture Hall C

13.00-14.20

AOR 6 | Lecture Hall B Ascending aorta and aortic arch

14.50-16.40

AOR 7 | Lecture Hall B Thoracic/Thoraco-abdominal aneurysm and dissections

12.45-14.30

PAD 3 | Lecture Hall C Challenges in PAD – long and calcified lesions, in-stent-restenosis, CLI, and wound healing

14.50-15.50

PAD 4 | Lecture Hall C Update on lipid-lowering therapy in carotid and peripheral atherosclerosis

15.50-16.40

PAD 5 | Lecture Hall C Update on periprocedural and long-term platelet inhibition and anticoagulation in PAD

17.00-18.00

PAD 6 | Lecture Hall C Short communications on Peripheral Arterial Disease

12.30-13.30

Mini-Symposium 2 | Conference Room 1 The venous challenge – successful strategies to treat venous lesions (Industry Sponsored)

15.00-16.00

Mini-Symposium 3 | Conference Room 1 Acute Type A Dissections: changing paradigms? (Industry Sponsored)

17.00-18.05

SPECIAL SESSION 2 | Lecture Hall B Team training, simulation, and augmented reality in the hybrid OR

Saturday, 8 December

09.00-10.00

VEN 1 | Lecture Hall B Short communications on Venous Diseases

10.00-11.05

VEN 2 | Lecture Hall B Acute and chronic deep vein thrombosis (DVT) – conservative and recanalizing strategies

11.30-13.00

VEN 3 | Lecture Hall B New developments in lower leg varicose vein disease

13.30-14.45

VEN 4 | Lecture Hall B The 2015 ESVS guidelines on chronic venous diseases – a critical review

CAD 1 | Lecture Hall B
Clinical and imaging variables in asymptomatic carotid patients with an increased late stroke risk – a critical review of the ESVS/ESC guidelines 2017

CAD 2 | Lecture Hall B
More news on carotid revascularization strategies and long-term outcomes in (a)symptomatic patients

CAD 3 | Lecture Hall B
Carotid Stenosis Trialist Collaboration (CSTC) session

CAD 4 | Lecture Hall C
Short communications on Carotid Artery Diseases

AOR 1 | Lecture Hall C
Short communications on Aortic Diseases

AOR 2 | Lecture Hall C
Dismantling AAAs – novel insights into disease mechanisms and future therapies

AOR 3 | Lecture Hall C
Biomechanical simulation of aortic aneurysms

PAD 1 | Lecture Hall B
Innovative imaging and below-the-knee treatment modalities

PAD 2 | Lecture Hall B
Peripheral and mesenteric vascular emergencies

Mini-Symposium 1 | Conference Room 1
Advance Therapy Outcomes in fenestrated and branched EVAR (Industry Sponsored)

SPECIAL SESSION 1 | Lecture Hall C
Hot topics in radiation protection 2018

CAD 5 | Lecture Hall C
Carotid Artery Disease (CAD) – from genes to therapies

CAD 6 | Lecture Hall C
Carotid plaque burden and vulnerability – assessment and clinical impact

AOR 4 | Lecture Hall B
The new AAA guidelines from the SVS, ESVS, Germany, and UK (NICE)

AOR 5 | Lecture Hall B
Endoleak prevention and management in complex aortic aneurysms

AOR 6 | Lecture Hall B
Ascending aorta and aortic arch

AOR 7 | Lecture Hall B
Thoracic/Thoraco-abdominal aneurysm and dissections

PAD 3 | Lecture Hall C
Challenges in PAD – long and calcified lesions, in-stent-restenosis, CLI, and wound healing

PAD 4 | Lecture Hall C
Update on lipid-lowering therapy in carotid and peripheral atherosclerosis

PAD 5 | Lecture Hall C
Update on periprocedural and long-term platelet inhibition and anticoagulation in PAD

PAD 6 | Lecture Hall C
Short communications on Peripheral Arterial Disease

Mini-Symposium 2 | Conference Room 1
The venous challenge – successful strategies to treat venous lesions (Industry Sponsored)

Mini-Symposium 3 | Conference Room 1
Acute Type A Dissections: changing paradigms? (Industry Sponsored)

SPECIAL SESSION 2 | Lecture Hall B
Team training, simulation, and augmented reality in the hybrid OR

VEN 1 | Lecture Hall B
Short communications on Venous Diseases

VEN 2 | Lecture Hall B
Acute and chronic deep vein thrombosis (DVT) – conservative and recanalizing strategies

VEN 3 | Lecture Hall B
New developments in lower leg varicose vein disease

VEN 4 | Lecture Hall B
The 2015 ESVS guidelines on chronic venous diseases – a critical review